Imdur: Effective Long-Term Angina Prevention and Management
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 180 | $0.28 | $51.23 $51.23 (0%) | 🛒 Add to cart |
| 270 | $0.24 | $76.85 $65.29 (15%) | 🛒 Add to cart |
| 360 | $0.22
Best per pill | $102.46 $79.36 (23%) | 🛒 Add to cart |
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.48 | $43.19 (0%) | 🛒 Add to cart |
| 120 | $0.45 | $57.59 $54.24 (6%) | 🛒 Add to cart |
| 180 | $0.41 | $86.39 $74.34 (14%) | 🛒 Add to cart |
| 270 | $0.39 | $129.58 $104.47 (19%) | 🛒 Add to cart |
| 360 | $0.35
Best per pill | $172.78 $124.56 (28%) | 🛒 Add to cart |
Synonyms | |||
Imdur (isosorbide mononitrate) is a long-acting nitrate medication specifically formulated for the prophylactic management of angina pectoris. It works by dilating blood vessels, which reduces the heart’s workload and oxygen demand, thereby preventing the painful symptoms of angina attacks. This prescription medication is a cornerstone in the long-term management of chronic coronary artery disease, offering patients a predictable and sustained therapeutic effect to improve functional capacity and quality of life. Its extended-release formulation is designed for convenient once-daily dosing, supporting consistent adherence to treatment regimens.
Features
- Active Pharmaceutical Ingredient (API): Isosorbide mononitrate.
- Pharmacological Class: Organic nitrate vasodilator.
- Available Formulations: Extended-release tablets (e.g., 30 mg, 60 mg, 120 mg strengths).
- Mechanism of Action: Biotransformed to release nitric oxide, a potent vasodilator, causing relaxation of vascular smooth muscle.
- Pharmacokinetics: Designed for prolonged release, providing a sustained plasma concentration over approximately 12-14 hours.
- Prescription Status: Available by prescription only, requiring diagnosis and monitoring by a healthcare professional.
Benefits
- Prophylactic Angina Prevention: Significantly reduces the frequency and severity of angina pectoris attacks, allowing for greater physical activity.
- Improved Exercise Tolerance: By reducing cardiac preload and afterload, it decreases myocardial oxygen consumption, enabling patients to engage in physical exertion with less chest pain.
- Convenient Dosing Regimen: The extended-release, once-daily formulation enhances patient compliance and provides consistent 24-hour therapeutic coverage.
- Enhanced Quality of Life: Effective management of angina symptoms reduces anxiety related to unpredictable pain episodes and supports a more active, normal lifestyle.
- Well-Established Safety Profile: As a member of the long-standing nitrate class, its effects and management are well-understood within the cardiology community.
Common use
Imdur is primarily indicated for the prevention of angina pectoris (chest pain) due to coronary artery disease. It is not intended for the acute termination of an angina attack, for which short-acting nitrates like nitroglycerin are used. Its role is prophylactic; it is used as part of a long-term management plan to reduce the overall occurrence of angina. It is often prescribed alongside other cardiac medications such as beta-blockers, calcium channel blockers, antiplatelet agents, and statins as part of a comprehensive cardiovascular risk reduction strategy.
Dosage and direction
The dosage of Imdur must be individualized based on patient response and the presence of hemodynamic effects like headache or hypotension. The typical starting dose for most patients is 30 mg or 60 mg administered orally once daily. The dose may be titrated upward as needed and tolerated. The maximum recommended dose is 240 mg once daily.
Critical Administration Instructions:
- Must be swallowed whole. Tablets should not be chewed, crushed, or split, as this will disrupt the extended-release mechanism and could lead to a rapid release of the entire dose.
- Taken consistently, preferably in the morning upon awakening.
- The initial dose and any dose increases should be monitored for signs of hypotension, especially when rising from a seated or lying position (orthostatic hypotension).
Precautions
- Tolerance Development: Continuous, 24-hour nitrate exposure can lead to the development of tolerance (loss of clinical effect). To prevent this, a daily nitrate-free interval of 10-14 hours is recommended. The once-daily dosing schedule of Imdur is designed to provide this interval naturally.
- Hypotension: Imdur can cause severe hypotension, particularly in volume-depleted patients or those already taking other antihypertensive drugs. Caution is advised when rising from a supine or seated position.
- Headache: Nitrate-induced headaches are very common, often dose-related, and may diminish with continued therapy. Over-the-counter analgesics may be used, but patients should not discontinue therapy without consulting their physician.
- Use in Specific Populations: Use with caution in patients with low systolic blood pressure, hypovolemia, hypertrophic cardiomyopathy, or constrictive pericarditis. Safety and efficacy in children have not been established.
- Pregnancy and Lactation: Use during pregnancy only if clearly needed. It is not known whether isosorbide mononitrate is excreted in human milk; caution is advised if administering to a nursing woman.
Contraindications
Imdur is contraindicated in patients with:
- Known hypersensitivity to isosorbide mononitrate, other nitrates, or any component of the formulation.
- Concurrent use of phosphodiesterase-5 (PDE-5) inhibitors (e.g., sildenafil, tadalafil, vardenafil) or soluble guanylate cyclase (sGC) stimulators (e.g., riociguat). Concomitant use can cause profound hypotension, syncope, or myocardial infarction.
- Marked anemia, increased intracranial pressure, or severe hypotension (e.g., systolic BP < 90 mmHg).
- Circulatory failure and shock.
Possible side effect
Common side effects are primarily related to vasodilation and are often dose-dependent. They may include:
- Headache (very frequent, often most severe at therapy initiation)
- Dizziness, lightheadedness, or orthostatic hypotension
- Flushing or feeling warm
- Nausea and vomiting
- Reflex tachycardia (a compensatory increase in heart rate) Less common but more serious side effects requiring medical attention include:
- Severe hypotension leading to syncope (fainting)
- Worsening angina symptoms (paradoxical effect)
- Dermatitis or skin rash (indicative of hypersensitivity)
Drug interaction
Imdur has significant and potentially dangerous interactions with several drug classes:
- Phosphodiesterase-5 (PDE-5) Inhibitors (e.g., Sildenafil, Tadalafil, Vardenafil): Absolutely contraindicated. Concomitant use can precipitate a life-threatening drop in blood pressure.
- Other Vasodilators and Antihypertensives: Additive hypotensive effects with other nitrate drugs, calcium channel blockers, beta-blockers, ACE inhibitors, angiotensin II receptor blockers, alpha-blockers, and alcohol. Dose adjustments may be necessary.
- Ergot Alkaloids (e.g., Ergotamine): Concomitant use may diminish the anti-anginal effect of Imdur and is not recommended.
- Medications for Erectile Dysfunction: Besides PDE-5 inhibitors, other classes used for erectile dysfunction can also cause hypotension.
Missed dose
If a dose of Imdur is missed, it should be taken as soon as remembered on the same day. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. The patient should never take a double dose to make up for the missed one. Taking two doses too close together significantly increases the risk of severe hypotension and other adverse effects.
Overdose
Symptoms of Imdur overdose are primarily related to its vasodilatory effects and can be severe due to the extended-release nature of the formulation. Symptoms include:
- Severe, throbbing headache
- Profound dizziness and fainting
- Visual disturbances
- Nausea, vomiting, and diarrhea
- Palpitations and tachycardia
- Profound hypotension, shock, cyanosis (bluish skin), methemoglobinemia, dyspnea, and syncope. Management: There is no specific antidote. Treatment is supportive and focuses on managing hypotension. Elevating the legs and administering intravenous fluids are first-line measures. In cases of severe hypotension, alpha-adrenergic agonists (e.g., phenylephrine) may be considered. Epinephrine is ineffective and should be avoided. Management of methemoglobinemia may require methylene blue administration. Immediate emergency medical attention is critical.
Storage
- Store Imdur tablets at room temperature (20°C to 25°C or 68°F to 77°F), away from light, moisture, and heat.
- Keep the medication in its original container, tightly closed.
- Keep out of reach of children and pets.
- Do not flush medications down the toilet or pour them into a drain. Dispose of unused medication via a official medicine take-back program or according to FDA guidelines.
Disclaimer
This information is for educational purposes only and is not a substitute for the professional medical advice, diagnosis, or treatment provided by a qualified healthcare provider. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided is not exhaustive and may not cover all possible uses, directions, precautions, interactions, or adverse effects.
Reviews
- “As a cardiologist with over 20 years of practice, Imdur remains a reliable and effective option for providing my stable angina patients with sustained symptomatic relief. The once-daily dosing is a significant advantage for long-term adherence.” – Cardiologist, MD
- “Clinical trials consistently demonstrate the efficacy of isosorbide mononitrate in reducing angina frequency and improving exercise duration. Its role in a multi-drug regimen for coronary artery disease is well-supported by evidence.” – Clinical Pharmacologist, PharmD
- “After starting on Imdur 60 mg, my patient reported a 70% reduction in weekly angina episodes. He is now able to walk his dog daily without experiencing chest pain, which has greatly improved his outlook on life.” – Cardiac Nurse Practitioner, NP